High-dose cyclophosphamide for graft-versus-host disease preventionLUZNIK, Leo; JONES, Richard J; FUCHS, Ephraim J et al.Current opinion in hematology. 2010, Vol 17, Num 6, pp 493-499, issn 1065-6251, 7 p.Article

Rapamycin promotes emergence of IL-10-secreting donor lymphocyte infusion-derived t cells without compromising their graft-versus-leukemia reactivityDURAKOVIC, Nadira; RADOJCIC, Vedran; POWELL, Jonathan et al.Transplantation. 2007, Vol 83, Num 5, pp 631-640, issn 0041-1337, 10 p.Article

Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow TransplantationLUZNIK, Leo; O'DONNELL, Paul V; FUCHS, Ephraim J et al.Seminars in oncology. 2012, Vol 39, Num 6, pp 683-693, issn 0093-7754, 11 p.Article

Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamideLUZNIK, Leo; JALLA, Sanju; ENGSTROM, Laura W et al.Blood. 2001, Vol 98, Num 12, pp 3456-3464, issn 0006-4971Article

Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimerasLUZNIK, Leo; SLANSKY, Jill E; JALLA, Sanju et al.Blood. 2003, Vol 101, Num 4, pp 1645-1652, issn 0006-4971, 8 p.Article

Effects of mixed hematopoietic chimerism in a mouse model of bone marrow transplantation for sickle cell anemiaIANNONE, Robert; LUZNIK, Leo; NOFFSINGER, Lori et al.Blood. 2001, Vol 97, Num 12, pp 3960-3965, issn 0006-4971Article

Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliteransSRINIVASAN, Mathangi; FLYNN, Ryan; SHLOMCHIK, Mark J et al.Blood. 2012, Vol 119, Num 6, pp 1570-1580, issn 0006-4971, 11 p.Article

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host diseaseLUZNIK, Leo; BOLANOS-MEADE, Javier; KASAMON, Yvette et al.Blood. 2010, Vol 115, Num 16, pp 3224-3230, issn 0006-4971, 7 p.Article

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell diseaseBOLANOS-MEADE, Javier; FUCHS, Ephraim J; LUZNIK, Leo et al.Blood. 2012, Vol 120, Num 22, pp 4285-4291, issn 0006-4971, 7 p.Article

Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cellsKANAKRY, Christopher G; HESS, Allan D; KARP, Judith E et al.Blood. 2011, Vol 117, Num 2, pp 608-617, issn 0006-4971, 10 p.Article

Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell eliminationRADOJCIC, Vedran; BEZAK, Karl B; SKARICA, Mario et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 1, pp 137-148, issn 0340-7004, 12 p.Article

High-dose cyclophosphamide for severe aplastic anemia: long-term follow-upBRODSKY, Robert A; CHEN, Allen R; JONES, Richard J et al.Blood. 2010, Vol 115, Num 11, pp 2136-2141, issn 0006-4971, 6 p.Article

Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouseDURAKOVIC, Nadira; RADOJCIC, Vedran; SKARICA, Mario et al.Blood. 2007, Vol 109, Num 10, pp 4564-4574, issn 0006-4971, 11 p.Article